McKesson Stock Price, News & Analysis

McKesson Corporation (NYSE: MCK) is set to release its second quarter fiscal 2022 financial results on November 1, 2021, after market close. The earnings conference call will take place at 4:30 PM Eastern Time, which will be available via a live webcast on McKesson's Investor Relations website. Investors can access the earnings press release, financial tables, and slide presentation online following the conference.

McKesson Corporation (NYSE:MCK) announced the election of Dr. Richard H. Carmona as an independent director, effective Sept. 6, 2021. Dr. Carmona brings extensive healthcare experience, including his role as the 17th Surgeon General of the United States. He aims to improve public health access, reflecting McKesson's mission to enhance care across various settings. The board chair, Edward Mueller, expressed confidence in Dr. Carmona’s contributions to the company's future direction.

AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) announced progress on the opioid claims settlement involving U.S. states and territories. As of August 21, 2021, 42 states, 5 territories, and Washington, D.C. have joined the settlement, allowing the process to move forward. This next phase includes a 120-day period for political subdivisions to join, ending January 2, 2022. If enough subdivisions participate, the settlement will take effect 60 days after that. The companies aim to focus on secure medication delivery while providing relief to affected communities.

McKesson Corporation (NYSE:MCK) has announced an upcoming Investor Day scheduled for December 8, 2021, in New York City. Interested stakeholders can access a live audio webcast along with presentation slides via the company's Investor Relations website. McKesson is recognized as a global leader in healthcare supply chain management and has received accolades such as being named a Most Admired Company by FORTUNE and a Best Place to Work by the Human Rights Campaign Foundation.

McKesson Corporation (NYSE: MCK) announced its fiscal 2022 first-quarter financial results on August 4th. Investors can review the results on McKesson’s Investor Relations website. A live earnings conference call will be held today at 4:30 PM ET, with a replay available for twelve months. McKesson is recognized as a leader in healthcare supply chain management and has received accolades including 'Most Admired Company' in the healthcare wholesaler category by FORTUNE. Visit www.mckesson.com for more information.

The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of $0.47 per share on July 23, 2021, marking a 12% increase from the previous quarter's $0.42. This dividend will be payable on October 1, 2021 to stockholders on record as of September 1, 2021. McKesson is recognized as a leader in healthcare supply chain management and has received accolades such as being a 'Most Admired Company' in the healthcare wholesaler category by FORTUNE.

McKesson Corporation (MCK) has announced an increase in its cash tender offer to purchase up to $922,154,000 of its outstanding Notes, up from the initial $500,000,000. This offer includes various series of Notes, with acceptance of all validly tendered and not withdrawn Notes prior to the Early Tender Time. The company expects to make payments on accepted Notes by July 23, 2021. The Offer will expire on August 4, 2021, unless extended. Barclays Capital Inc. and Citigroup Global Markets Inc. are leading the transaction.

McKesson Corporation (NYSE: MCK) announced early tender results for its cash tender offer to purchase up to $500 million of various Notes. As of July 21, 2021, the company intends to increase the Tender Cap to $922,154,000, after receiving $922,154,000 of validly tendered Notes. This includes Series like 6.00% Notes due 2041 and 4.883% Notes due 2044, with acceptance expected for 100% of valid tenders submitted by the Early Tender Time. The Offer expires on August 4, 2021, unless extended.

AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) announced a proposed settlement addressing the majority of opioid lawsuits from state and local entities. The settlement, contingent on participation from states and political subdivisions, could provide up to $21 billion over 18 years. Contributions include $6.4 billion from each AmerisourceBergen and Cardinal Health, and $7.9 billion from McKesson. The settlement is seen as a step towards resolving opioid claims, with strong legal defenses maintained in pending litigation if not finalized.